New York, May 20, 2014 -- Moody's Investors Service said that today's announcement of a global patent litigation settlement related to transcatheter heart valve (THV) technology is credit positive for both Medtronic, Inc. (A2 stable) and Edwards Lifesciences Corporation (Baa3 stable). However, there is no effect on either company's ratings at this time. For further information, please see Moody's Issuer Comments on Medtronic and Edwards on www.moodys.com.

Vollständigen Artikel bei Moodys lesen